Jeffrey Mittleman

Practice Areas

Corporate Services | Compliance Services | Mergers and Acquisitions | Healthcare & Life Sciences | Healthcare Transactions | Health Plans and Health Insurance | HIPAA and Healthcare Privacy | Healthcare & Life Sciences Policy | Long-Term Care Facilities | Hospitals and Health Systems | Healthcare Fraud and Abuse | Labor, Employment and Benefits | Pharmaceutical, Biotechnology and Medical Device Industries | Private Equity | Healthcare Litigation | Regulatory and Federal Litigation | Risk and Crisis Management | Global Cybersecurity and Privacy Policy and Regulation | China Practice | Representations and Warranties Insurance

Professional Memberships

American Bar Association, Business Law Section

American Health Lawyers Association, Part D Task Force

Boston Bar Association, Health Law Section Steering Committee, 2011-2012

Massachusetts Bar Association

Health Law Advisory Council, American University's Washington College of Law

Crohn's & Colitis Foundation of America, New England Chapter, Board Member and Past President

Crohn's & Colitis Foundation of America, National Board of Trustees

Greater Boston Legal Services, Board Member

Boston Center for Community Justice, Development Committee

Greater Boston Chamber of Commerce, Boston's Future Leaders

Work Highlights

Jeffrey W. Mittleman is an attorney in the Healthcare Section of Holland & Knight. He is also co-leader of the firm's Healthcare & Life Sciences Industry Group and the Healthcare Regulatory and Enforcement Practice Group. He practices in the areas of health, regulatory and corporate law. With more than 25 years of experience, he represents clients in a variety of sectors within the healthcare industry, including health plans (both fully and self-insured), PPOs, HMOs, insurers, pharmacy benefit managers, pharmaceutical manufacturers (including a number of companies specializing in oncology medicine), medical device companies, retail pharmacies, long-term care pharmacies, specialty pharmacies, infusion pharmacies, compounding pharmacies, mail order pharmacies, wholesale drug distributors, dialysis companies, e-health, disease management and healthcare technology companies. Mr. Mittleman counsels clients in a variety of corporate and contractual transactions, including mergers and acquisitions, joint ventures, licensing, financing and services-related transactions. He also advises clients on fraud and abuse issues including the Anti-Kickback Statute, Stark Law and the Corporate Practice of Medicine, and the structuring of compliance and ethics programs, Medicare, Medicaid, ERISA, HIPAA, licensing, state insurance and managed care law. In addition, Mr. Mittleman has significant experience advising health plans in connection with the drafting of plan documents, ASO contracting and other regulatory issues.

Mr. Mittleman represents private equity firms in connection with investments in portfolio companies that are engaged in the healthcare and life sciences industries. He guides private equity clients through every stage of an acquisition, from evaluation of the opportunity and due diligence to deal structuring and negotiation to closing.

Mr. Mittleman has published several articles and spoken at conferences regarding various health law issues, including compliance, fraud and abuse, pharmacy law, drug distribution and managed care.

Mr. Mittleman holds various leadership positions within the firm, including serving on the firm's Directors Committee. From 2007-2017, he served as the Boston office Public & Charitable Services Partner and from 2009-2017, he served as the co-chair of the Boston office's Diversity Committee.